Progyny, Inc. Capex to Sales

Capex to Sales of PGNY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Capex to Sales growth rates and interactive chart.


Highlights and Quick Summary

  • Capex to Sales for the quarter ending September 29, 2021 was 0.01 (a 78.79% increase compared to previous quarter)
  • Year-over-year quarterly Capex to Sales increased by 490.0%
  • Annual Capex to Sales for 2020 was 0.0 (a -76.74% decrease from previous year)
  • Annual Capex to Sales for 2019 was 0.01 (a 134.55% increase from previous year)
  • Annual Capex to Sales for 2018 was 0.01 (a -56.35% decrease from previous year)
  • Twelve month Capex to Sales ending September 29, 2021 was 0.0 (a 47.83% increase compared to previous quarter)
  • Twelve month trailing Capex to Sales increased by 13.33% year-over-year
Trailing Capex to Sales for the last four month:
29 Sep '21 29 Jun '21 30 Mar '21 30 Dec '20
0.0 0.0 0.0 0.0
Visit stockrow.com/PGNY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Capex to Sales of Progyny, Inc.

Most recent Capex to Salesof PGNY including historical data for past 10 years.

Interactive Chart of Capex to Sales of Progyny, Inc.

Progyny, Inc. Capex to Sales for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 0.01 0.0 0.0
2020 0.0 0.0 0.0 0.01 0.0
2019 0.04 0.01 0.0 0.0 0.01
2018 0.0 0.0 0.0 0.01
2017 0.0 0.01

Business Profile of Progyny, Inc.

Sector: Healthcare
Industry: Health Information Services
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.